Clinical Study

Stu022015-069 A Randomized Phase III Study Of Sublobar Resection (Sr) Versus Stereotactic Ablative Radiotherapy (Sabr) In High Risk Patients With Stage I Non-Small Cell Lung Cancer (Nsclc)

Posted Date: May 15, 2019

  • Investigator: Sandra Starnes
  • Specialties: Cancer, Lung Cancer, Oncology
  • Type of Study: Drug

The purpose of this study is to compare the results of two standard treatments. The two treatments include sublobar resection and radiation. Sublobar resection is the removal of a small portion of a lung. Radiation, orstereotactic ablative radiotherapy, is radiation given by a specialized x-ray mach

Criteria:

To Be Eligible To Participate In This Study, Participants Must Have Lung Cancer, Or A Lung Nodule Su

Keywords:

Phase Iii, Stu-022015-069, Lung, Non-Small Cell Lung , Cancer

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.